Endonuclease G promotes cell death of non-invasive human breast cancer cells

Experimental Cell Research

Volumn 312, Issue 20, 2006, Pages 4139-4149

  Basnakian, Alexei G ^a,c   Apostolov, Eugene O ^a   Yin, Xiaoyan ^a   Abiri, Stanley O ^b   Stewart, Anna G ^a   Singh, Amar B ^a   Shah, Sudhir V ^a,c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b PHILANDER SMITH COLLEGE   (United States)

^c CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

Apoptosis; Breast cancer; Chemotherapy; Differentiation; DNase I; Invasiveness

Indexed keywords

CAMPTOTHECIN; COLLAGENASE 3; ENDONUCLEASE; ENDONUCLEASE G; ESTROGEN RECEPTOR; ETOPOSIDE; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER INVASION; CARCINOMA IN SITU; CELL DEATH; CELL DIFFERENTIATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 33751546898     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2006.09.012     Document Type: Article

References (52)

1. Thompson E.W., Paik S., Brunner N., Sommers C.L., Zugmaier G., Clarke R., Shima T.B., Torri J., Donahue S., and Lippman M.E. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J. Cell. Physiol. 150 (1992) 534-544
2. Meyer J.S., Koehm S.L., Hughes J.M., Higa E., Wittliff J.L., Lagos J.A., and Manes J.L. Bromodeoxyuridine labeling for S-phase measurement in breast carcinoma. Cancer 71 (1993) 3531-3540
3. Kim M.S., Kang H.J., and Moon A. Inhibition of invasion and induction of apoptosis by curcumin in H-ras-transformed MCF10A human breast epithelial cells. Arch. Pharm. Res. 24 (2001) 349-354
4. Fernandez Y., Gu B., Martinez A., Torregrosa A., and Sierra A. Inhibition of apoptosis in human breast cancer cells: role in tumor progression to the metastatic state. Int. J. Cancer 101 (2002) 317-326
5. Mommers E.C., van Diest P.J., Leonhart A.M., Meijer C.J., and Baak J.P. Balance of cell proliferation and apoptosis in breast carcinogenesis. Breast Cancer Res. Treat. 58 (1999) 163-169
6. Vineis P. Cancer as an evolutionary process at the cell level: an epidemiological perspective. Carcinogenesis 24 (2003) 1-6
7. Shilkaitis A., Green A., Steele V., Lubet R., Kelloff G., and Christov K. Neoplastic transformation of mammary epithelial cells in rats is associated with decreased apoptotic cell death. Carcinogenesis 21 (2000) 227-233
8. Hengartner M.O. Apoptosis. DNA destroyers. Nature 412 27 (2001) 29
9. Ploski J.E., and Aplan P.D. Characterization of DNA fragmentation events caused by genotoxic and non-genotoxic agents. Mutat. Res. 473 (2001) 169-180
10. Shrivastava P., Sodhi A., and Ranjan P. Anticancer drug-induced apoptosis in human monocytic leukemic cell line U937 requires activation of endonuclease(s). Anticancer Drugs 11 (2000) 39-48
11. Polzar B., Peitsch M.C., Loos R., Tschopp J., and Mannherz H.G. Overexpression of deoxyribonuclease I (DNase I) transfected into COS-cells: its distribution during apoptotic cell death. Eur. J. Cell Biol. 62 (1993) 397-405
12. Krieser R.J., and Eastman A. The cloning and expression of human deoxyribonuclease II. A possible role in apoptosis. J. Biol. Chem. 273 (1998) 30909-30914
13. Li L.Y., Luo X., and Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 412 (2001) 95-99
14. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., and Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391 (1998) 43-50
15. Shiokawa D., Ohyama H., Yamada T., and Tanuma S. Purification and properties of DNase gamma from apoptotic rat thymocytes. Biochem. J. 326 Pt 3 (1997) 675-681
16. Nagata S., Nagase H., Kawane K., Mukae N., and Fukuyama H. Degradation of chromosomal DNA during apoptosis. Cell Death Differ. 10 (2003) 108-116
17. Napirei M., Karsunky H., Zevnik B., Stephan H., Mannherz H.G., and Moroy T. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat. Genet. 25 (2000) 177-181
18. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
19. Basnakian A.G., and James S.J. Quantification of 3 OH DNA breaks by random oligonucleotide-primed synthesis (ROPS) assay. DNA Cell Biol. 15 (1996) 255-262
20. Basnakian A.G., Ueda N., Kaushal G.P., Mikhailova M.V., and Shah S.V. DNase I-like endonuclease in rat kidney cortex that is activated during ischemia/reperfusion injury. J. Am. Soc. Nephrol. 13 (2002) 1000-1007
21. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
22. Frahm S.O., Rudolph P., Dworeck C., Zott B., Heidebrecht H., Steinmann J., Neppert J., and Parwaresch R. Immunoenzymatic detection of the new proliferation associated protein p100 by means of a cellular ELISA: specific detection of cells in cell cycle phases S, G2 and M. J. Immunol. Methods 223 (1999) 147-153
23. Basnakian A.G., Kaushal G.P., Ueda N., and Shah S.V. Oxidant mechanisms in toxic acute renal failure. In: Tarloff J.B., and Lash L.H. (Eds). Toxicology of the Kidney. 3rd Ed. (2005) 499-523
24. Widlak P., Li L.Y., Wang X., and Garrard W.T. Action of recombinant human apoptotic endonuclease G on naked DNA and chromatin substrates: cooperation with exonuclease and DNase I. J. Biol. Chem. 276 (2001) 48404-48409
25. Barry M.A., and Eastman A. Identification of deoxyribonuclease II as an endonuclease involved in apoptosis. Arch. Biochem. Biophys. 300 (1993) 440-450
26. Howell D.P., Krieser R.J., Eastman A., and Barry M.A. Deoxyribonuclease II is a lysosomal barrier to transfection. Mol. Ther. 8 (2003) 957-963
27. Basnakian A.G., Apostolov E.O., Yin X., Napirei M., Mannherz H.G., and Shah S.V. Cisplatin nephrotoxicity is mediated by deoxyribonuclease I. J. Am. Soc. Nephrol. 16 (2005) 697-702
28. Page D.L. Breast lesions, pathology and cancer risk. Breast J. 10 Suppl 1 (2004) S3-S4
29. Mallon E., Osin P., Nasiri N., Blain I., Howard B., and Gusterson B. The basic pathology of human breast cancer. J. Mammary Gland Biol. Neoplasia 5 (2000) 139-163
30. Koch M., de Miguel M., Hofler H., and Diaz-Cano S.J. Kinetic profiles of intraepithelial and invasive prostatic neoplasias: the key role of down-regulated apoptosis in tumor progression. Virchows Arch. 436 (2000) 413-420
31. Sekharam M., Zhao H., Sun M., Fang Q., Zhang Q., Yuan Z., Dan H.C., Boulware D., Cheng J.Q., and Coppola D. Insulin-like growth factor 1 receptor enhances invasion and induces resistance to apoptosis of colon cancer cells through the Akt/Bcl-x(L) pathway. Cancer Res. 63 (2003) 7708-7716
32. Hashimoto S., Koji T., Kohara N., Kanematsu T., and Nakane P.K. Frequency of apoptosis relates inversely to invasiveness and metastatic activity in human colorectal cancer. Virchows Arch. 431 (1997) 241-248
33. Zhang X., Xu Q., and Saiki I. Quercetin inhibits the invasion and mobility of murine melanoma B16-BL6 cells through inducing apoptosis via decreasing Bcl-2 expression. Clin. Exp. Metastasis 18 (2000) 415-421
34. Xiao E.H., Hu G.D., and Li J.Q. Relationship between apoptosis and invasive and metastatic potential of hepatocellular carcinoma. Hepatobiliary Pancreat. Dis. Int. 1 (2002) 574-576
35. Wyllie A.H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284 (1980) 555-556
36. Nagata S. Apoptotic DNA fragmentation. Exp. Cell Res. 256 (2000) 12-18
37. Folle G.A., Martinez-Lopez W., Boccardo E., and Obe G. Localization of chromosome breakpoints: implication of the chromatin structure and nuclear architecture. Mutat. Res. 404 (1998) 17-26
38. Ruiz-Carrillo A., and Renaud J. Endonuclease G: a (dG)n X (dC)n-specific DNase from higher eukaryotes. EMBO J. 6 (1987) 401-407
39. Cote J., Renaud J., and Ruiz-Carrillo A. Recognition of (dG)n.(dC)n sequences by endonuclease G. Characterization of the calf thymus nuclease. J. Biol. Chem. 264 (1989) 3301-3310
40. Cote J., and Ruiz-Carrillo A. Primers for mitochondrial DNA replication generated by endonuclease G. Science 261 (1993) 765-769
41. Ohsato T., Ishihara N., Muta T., Umeda S., Ikeda S., Mihara K., Hamasaki N., and Kang D. Mammalian mitochondrial endonuclease G. Digestion of R-loops and localization in intermembrane space. Eur. J. Biochem. 269 (2002) 5765-5770
42. Zhang J., Dong M., Li L., Fan Y., Pathre P., Dong J., Lou D., Wells J.M., Olivares-Villagomez D., Van Kaer L., Wang X., and Xu M. Endonuclease G is required for early embryogenesis and normal apoptosis in mice. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 15782-15787
43. Irvine R.A., Adachi N., Shibata D.K., Cassell G.D., Yu K., Karanjawala Z.E., Hsieh C.L., and Lieber M.R. Generation and characterization of endonuclease G null mice. Mol. Cell. Biol. 25 (2005) 294-302
44. Yang X.H., Sladek T.L., Liu X., Butler B.R., Froelich C.J., and Thor A.D. Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis. Cancer Res. 61 (2001) 348-354
45. Liu Z., Brattain M.G., and Appert H. Differential display of reticulocalbin in the highly invasive cell line, MDA-MB-435, versus the poorly invasive cell line, MCF-7. Biochem. Biophys. Res. Commun. 231 (1997) 283-289
46. Zajchowski D.A., Bartholdi M.F., Gong Y., Webster L., Liu H.L., Munishkin A., Beauheim C., Harvey S., Ethier S.P., and Johnson P.H. Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res. 61 (2001) 5168-5178
47. Oyama T., Take H., Hikino T., Iino Y., and Nakajima T. Immunohistochemical expression of metallothionein in invasive breast cancer in relation to proliferative activity, histology and prognosis. Oncology 53 (1996) 112-117
48. Kun Y., How L.C., Hoon T.P., Bajic V.B., Lam T.S., Aggarwal A., Sze H.G., Bok W.S., Yin W.C., and Tan P. Classifying the estrogen receptor status of breast cancers by expression profiles reveals a poor prognosis subpopulation exhibiting high expression of the ERBB2 receptor. Hum. Mol. Genet. 12 (2003) 3245-3258
49. Hendrix M.J., Seftor E.A., Seftor R.E., and Trevor K.T. Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior. Am. J. Pathol. 150 (1997) 483-495
50. Thomas P.A., Kirschmann D.A., Cerhan J.R., Folberg R., Seftor E.A., Sellers T.A., and Hendrix M.J. Association between keratin and vimentin expression, malignant phenotype, and survival in postmenopausal breast cancer patients. Clin. Cancer Res. 5 (1999) 2698-2703
51. Dandachi N., Hauser-Kronberger C., More E., Wiesener B., Hacker G.W., Dietze O., and Wirl G. Co-expression of tenascin-C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumour progression: correlation with histopathological parameters, hormone receptors, and oncoproteins. J. Pathol. 193 (2001) 181-189
52. Freije J.M., Diez-Itza I., Balbin M., Sanchez L.M., Blasco R., Tolivia J., and Lopez-Otin C. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J. Biol. Chem. 269 (1994) 16766-16773